贝达药业：目前港股上市相关工作正有序推进中

Group 1 - The company, BeiGene, submitted an application for the issuance of overseas listed shares (H shares) and for listing on the Hong Kong Stock Exchange on September 29, 2025 [2] - The application materials for this issuance and listing were published on the Hong Kong Stock Exchange's website on the same day [2] - The related work for the Hong Kong stock listing is progressing in an orderly manner, and the company will announce any significant developments in a timely manner [2]